LHI: Set, I.V. Fluid Transfer

Product code LHI, “Set, I.V. Fluid Transfer” in FDA's classification database, is a Class II device type under 21 CFR 880.5440 (intravascular administration set), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 206 clearances under LHI, 67 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LHI
Regulation
21 CFR 880.5440
Class
II
Panel
General Hospital
Clearances
206
Most recent
Jun 12, 2026
Median review, last 2 years
132 days
Third-party review
Eligible
Implant
No

What it covers

An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.

The identification in 21 CFR 880.5440, intravascular administration set. FDA gives LHI no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K252987ADRx™ Admixture DeviceEpic Medical Pte. , Ltd.Jun 12, 2026Traditional
K260301Vial AdapterHangzhou Qiantang Longyue Biotechnology Co., Ltd.Jun 5, 2026Traditional
K250345Medline Bag DecanterMedline Industries, LPOct 24, 2025Traditional
K251715FlowArt® Vial Access Device VentedAsset MedikalOct 14, 2025Traditional
K251676Medline Microtek C-Flo Bag Decanter, Sterile (2000S); Medline Microtek Bag Decanter II, Sterile (2002S); Medline Microtek Vial Decanter, Sterile (2006S); Medline Microtek Transfer Device, Sterile (2008S)Microtek Medical, LLCSep 16, 2025Traditional
K243404HyHub™ and HyHub™ Duo Vial Access DevicesTakeda PharmaceuticalsJul 18, 2025Traditional
K240761Arisure® Closed Male Luer with Spike Adapter (YM060)Yukon Medical, LLCMar 21, 2025Traditional
K243985Rio™ Drug Reconstitution Transfer DeviceIcu Medical, Inc.Jan 22, 2025Traditional
K243486SmartSiteTM Vented Vial Access DeviceYukon Medical, LLCDec 6, 2024Traditional
K241976nextaro® va, 15mm, 5µmSfm Medical Devices GmbHSep 6, 2024Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 206 with a free account)

Clearances by year

67 LHI 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)2197
20256196
20249166
2023590
20225300
20213396
20203189
20194247
20181199
2017556
20163159
2015399
2014663
20134102
20125127
2011399

Who submits

41 applicants cleared a LHI device since 2011. 48% of the clearances went to applicants in United States, then Israel (16%), China (10%) and Germany (6%). By type: Traditional 82%, Special 15% and Abbreviated 3%. 10 went through a third-party review organization.

ApplicantClearances since 2011
Yukon Medical, LLC6
West Pharma. Services IL, Ltd.5
B.Braun Medical, Inc.4
Hangzhou Qiantang Longyue Biotechnology Co., Ltd.4
Medimop Medical Projects, Ltd.4
Medsource International, LLC3
Sfm Medical Devices GmbH3
Avenir Performance Europeenne Medical (Apem)2

How FDA classifies it

Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.

From 21 CFR 880.5440. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 880.5440 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LHI clearances declared.

Ask about LHI

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LHI

What is FDA product code LHI?

Product code LHI, “Set, I.V. Fluid Transfer” in FDA's classification database, is a Class II device type under 21 CFR 880.5440 (intravascular administration set), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 206 clearances under LHI, 67 of them since 2011.

How many 510(k) clearances are there under LHI?

FDA’s 510(k) database listed 206 clearances under LHI as of Oct 29, 2026, 67 of them decided since 2011; the most recent decision was Jun 12, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a LHI 510(k)?

For the 9 LHI clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 132 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LHI clearances?

Since 2011: Yukon Medical, LLC (6), West Pharma. Services IL, Ltd. (5), B.Braun Medical, Inc. (4), Hangzhou Qiantang Longyue Biotechnology Co., Ltd. (4) and Medimop Medical Projects, Ltd. (4). 41 applicants have cleared a LHI device in that time.

Sources

  1. FDA product classification: LHI · Product Classification database
  2. 21 CFR 880.5440: Intravascular administration set · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LHI · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LHIGet an email when FDA clears, recalls or publishes guidance for LHI devices.

Know what FDA already cleared.